Repligen Stock News

WALTHAM, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtu

Repligen (RGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

WASHINGTON, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research''s recent analysis of the Global Pharmaceutical Membrane Filtration Market finds that growth in the production of biopharmaceuticals is expediting market growth. Primarily driven by advancements in nanofiltration technologies, the total global Pharmaceutical Membrane Filtration Market is estimated to reach USD 14.16 Billion by 2028, up from USD 6.48 Billion in 2021, at a Compound Annual Growth Rate (CAGR) of 11.8%. Furthermore, the surging adoption of single-use technologies is also anticipated to augment the growth of the global Pharmaceutical Membrane Filtration Market, states Vantage Market Research, in a report, titled: " Pharmaceutical Membrane Filtration Market by Product (Filters, Systems, Accessories), by Technique (Microfiltration, Ultrafiltration, Nanofiltration, Reverse Osmosis), by Material (PES, PVDF, Nylon, PTFE), by Application (Final Product Processing, API Filtration, Sterile Filtration, Protein Purification), by Region (North America, Europe, Asia Pacific, Middle East & Africa) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)".

Stocks, especially the once high flying technology stocks, had a lousy start to the new year. QQQ lost 9% of its value in January.

Webcast and Conference Call to Be Held Thursday, February 17, 2022 at 8:30 a.m. EST Webcast and Conference Call to Be Held Thursday, February 17, 2022 at 8:30 a.m. EST

Webcast and Conference Call to Be Held Thursday, February 17, 2022 at 8:30 a.m. EST Webcast and Conference Call to Be Held Thursday, February 17, 2022 at 8:30 a.m. EST

Webcast and Conference Call to Be Held Thursday, February 17, 2022 at 8:30 a.m. EST Webcast and Conference Call to Be Held Thursday, February 17, 2022 at 8:30 a.m. EST

Regeneron, Vertex Pharmaceuticals, Dynavax Technologies Corp. and Repligen are highlighted in this Industry Outlook article.

New drug approvals and development of treatments for COVID-19 should maintain momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and pipeline progress position VRTX, REGN, DVA

Style Box ETF report for RFG

These two companies offer under-the-radar ways to invest in the healthcare space.

The FDA agrees to the initiation of rolling submission of Gamida's (GMDA) BLA for its lead blood cancer candidate, omidubicel. The stock rises more than 22% on in response.

Style Box ETF report for IVOG

Smart Beta ETF report for PBE

And they're built to remain among the world's fastest-growing companies as well.